NCT01457196View on ClinicalTrials.gov

Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions

NACompletedINTERVENTIONAL

Enrollment

2,798

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

June 6, 2018

Study Completion Date

June 6, 2018

Conditions

Neoplasm

Interventions

DIAGNOSTIC_TEST

Tumor Genetic Sequencing

This study will look at genetic material from a sample of the subjects tumor, look at certain changes in the genetic material, and see if these changes are related to the subjects cancer.

Trial Locations (1)

27599

University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill

All Listed Sponsors

lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT01457196 - Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions | Biotech Hunter | Biotech Hunter